Clinical Trials Logo

Clinical Trial Summary

This study is aimed to evaluate difference of the 2 year recurrence free survival after pancreaticoduodenectomy for pancreatic cancer between artery-first approach and conventional procedure groups.


Clinical Trial Description

The patients will be divided into 2 groups conventional group: The patients who included this group will undergo conventional pancreaticoduodenectomy (PD) or pylorus preserving pancreaticoduodenectomy (PPPD). We will identify and isolate superior mesenteric vein (SMV) before pancreatic resection. The surgeon will dissect tissue around superior mesenteric artery (SMA) and uncinate process of pancreas along the SMA. Experimental group: The patients who included this group will undergo PD or PPPD including total pancreatic mesopancreas excision and superior mesenteric artery approach. Before pancreatic transection, the surgeon will isolate superior mesenteric vein (SMV) and superior mesenteric artery (SMA). And the surgeon will dissect nerve plexus and lymph node around SMA. inferior pancreaticoduodenal artery (IPDA) and first jejunal artery will be identified and the surgeon will ligate according to surgical margin. Anastomosis will be performed as usual manners. Postoperative manage is same in two groups. The investigators will compared 2 years recurrence free survival rate between conventional and experimental groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04136522
Study type Interventional
Source Asan Medical Center
Contact Woohyung Lee, MD.
Phone +82-02-3010-3993
Email ywhnet@gmail.com
Status Recruiting
Phase N/A
Start date January 10, 2020
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04053231 - Hepatocarcinoma Recurrence on the Liver Study - Part2
Recruiting NCT04499833 - HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma N/A
Recruiting NCT03423992 - Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas Phase 1
Active, not recruiting NCT04129606 - Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy N/A
Completed NCT03547388 - Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment Phase 1
Recruiting NCT03457389 - Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma N/A
Completed NCT04656769 - Analgesia aNd caNcer recUrrence Lung cAncer Resection
Recruiting NCT04640363 - Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
Recruiting NCT03658785 - Immunotherapy for the Treatment of Advanced Solid Tumor Phase 1/Phase 2